IBDEI2MK ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,44052,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,44052,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,44052,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,44053,0)
 ;;=E29.1^^200^2220^52
 ;;^UTILITY(U,$J,358.3,44053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44053,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,44053,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,44053,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,44054,0)
 ;;=E55.9^^200^2220^59
 ;;^UTILITY(U,$J,358.3,44054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44054,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,44054,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,44054,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,44055,0)
 ;;=E66.01^^200^2220^38
 ;;^UTILITY(U,$J,358.3,44055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44055,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,44055,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,44055,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,44056,0)
 ;;=E66.8^^200^2220^42
 ;;^UTILITY(U,$J,358.3,44056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44056,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,44056,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,44056,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,44057,0)
 ;;=E66.9^^200^2220^43
 ;;^UTILITY(U,$J,358.3,44057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44057,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,44057,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,44057,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,44058,0)
 ;;=E74.39^^200^2220^35
 ;;^UTILITY(U,$J,358.3,44058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44058,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,44058,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,44058,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,44059,0)
 ;;=E83.30^^200^2220^46
 ;;^UTILITY(U,$J,358.3,44059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44059,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,44059,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,44059,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,44060,0)
 ;;=E83.51^^200^2220^28
 ;;^UTILITY(U,$J,358.3,44060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44060,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,44060,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,44060,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,44061,0)
 ;;=E83.52^^200^2220^26
 ;;^UTILITY(U,$J,358.3,44061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44061,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,44061,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,44061,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,44062,0)
 ;;=E87.5^^200^2220^27
 ;;^UTILITY(U,$J,358.3,44062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44062,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,44062,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,44062,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,44063,0)
 ;;=E89.2^^200^2220^48
 ;;^UTILITY(U,$J,358.3,44063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44063,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,44063,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,44063,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,44064,0)
 ;;=E89.6^^200^2220^47
 ;;^UTILITY(U,$J,358.3,44064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44064,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,44064,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,44064,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,44065,0)
 ;;=L68.0^^200^2220^25
 ;;^UTILITY(U,$J,358.3,44065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,44065,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,44065,1,4,0)
 ;;=4^L68.0
